These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 31707785

  • 21. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM, Greenwood-Quaintance KE, Schuetz AN, Ko KS, Peck KR, Song JH, Patel R.
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [Abstract] [Full Text] [Related]

  • 22. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC, Su LH, Chiu CH, Kuo AJ, Liu TP, Lee MH, Su IN, Wu TL.
    Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
    [Abstract] [Full Text] [Related]

  • 23. First detected OXA-50 carbapenem-resistant clinical isolates Pseudomonas aeruginosa from Bulgaria and interplay between the expression of main efflux pumps, OprD and intrinsic AmpC.
    Petrova A, Feodorova Y, Miteva-Katrandzhieva T, Petrov M, Murdjeva M.
    J Med Microbiol; 2019 Dec; 68(12):1723-1731. PubMed ID: 31746726
    [Abstract] [Full Text] [Related]

  • 24. Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.
    Peña C, Suarez C, Tubau F, Juan C, Moya B, Dominguez MA, Oliver A, Pujol M, Ariza J.
    J Clin Microbiol; 2009 Aug; 47(8):2381-7. PubMed ID: 19494059
    [Abstract] [Full Text] [Related]

  • 25. Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil.
    Campana EH, Xavier DE, Petrolini FV, Cordeiro-Moura JR, Araujo MR, Gales AC.
    Braz J Infect Dis; 2017 Aug; 21(1):57-62. PubMed ID: 27916604
    [Abstract] [Full Text] [Related]

  • 26. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 27. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 28. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 29. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ.
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT, Khalili Y, Ghotaslou R, Yousefi S, Kafil HS, Naghili B, Sheikhalizadeh V.
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [Abstract] [Full Text] [Related]

  • 31. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa isolated from four medical centres in Iran.
    Khalili Y, Omidnia P, Goli HR, Zamanlou S, Babaie F, Zahedi Bialvaei A, Esmailkhani A.
    Mol Biol Rep; 2022 Sep; 49(9):8281-8289. PubMed ID: 35657451
    [Abstract] [Full Text] [Related]

  • 32. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S.
    Pathol Biol (Paris); 2009 Sep; 57(7-8):530-5. PubMed ID: 18977099
    [Abstract] [Full Text] [Related]

  • 33. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.
    Hocquet D, Bertrand X, Köhler T, Talon D, Plésiat P.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1887-94. PubMed ID: 12760863
    [Abstract] [Full Text] [Related]

  • 34. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Suresh M, Nithya N, Jayasree PR, Vimal KP, Manish Kumar PR.
    World J Microbiol Biotechnol; 2018 May 30; 34(6):83. PubMed ID: 29846800
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.
    Wi YM, Choi JY, Lee JY, Kang CI, Chung DR, Peck KR, Song JH, Ko KS.
    Antimicrob Agents Chemother; 2017 Jun 30; 61(6):. PubMed ID: 28373200
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.
    Cabot G, Ocampo-Sosa AA, Tubau F, Macia MD, Rodríguez C, Moya B, Zamorano L, Suárez C, Peña C, Martínez-Martínez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI).
    Antimicrob Agents Chemother; 2011 May 30; 55(5):1906-11. PubMed ID: 21357294
    [Abstract] [Full Text] [Related]

  • 37. Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa.
    Fusté E, López-Jiménez L, Segura C, Gainza E, Vinuesa T, Viñas M.
    J Med Microbiol; 2013 Sep 30; 62(Pt 9):1317-1325. PubMed ID: 23722434
    [Abstract] [Full Text] [Related]

  • 38. Carbapenem-resistant-only Pseudomonas aeruginosa infection in patients formerly infected by carbapenem-susceptible strains.
    Tsai MH, Wu TL, Su LH, Lo WL, Chen CL, Liang YH, Chiu CH.
    Int J Antimicrob Agents; 2014 Dec 30; 44(6):541-5. PubMed ID: 25264129
    [Abstract] [Full Text] [Related]

  • 39. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
    Hocquet D, Nordmann P, El Garch F, Cabanne L, Plésiat P.
    Antimicrob Agents Chemother; 2006 Apr 30; 50(4):1347-51. PubMed ID: 16569851
    [Abstract] [Full Text] [Related]

  • 40. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A.
    Microb Drug Resist; 2013 Oct 30; 19(5):355-61. PubMed ID: 23600605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.